Study flow diagram. by Sergio R. Thomaz (20308465)

Subjects:

Changes in maximal strength within each group after treatment. by Sergio R. Thomaz (20308465)

Subjects:

ΔVO₂ (ml/min), ΔVO₂/HR and ΔVE/VCO₂ slope baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

Subjects:

Clinical characteristics of the study population. by Sergio R. Thomaz (20308465)

Subjects:

Experimental Investigation of Hydrodynamic Characteristics in Industrial Pulsed Liquid–Liquid Extraction Column by Xiucheng Yu (22634359)

“…Moreover, regardless of whether the aqueous or organic phase is used as the dispersed phase, it has been newly observed that the MRT decreases with increasing pulsation intensity in PDDC, while it increases under the same conditions in PSPC. …”

Study on the expression of mRNA related to biofilm formation of <i>C. albicans</i> by CSR extract (100 μg/mL). by Xuxi Cheng (22453447)

Table 1_Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China.do... by Hongxiang Ji (11235519)

“…</p>Results<p>In total, we selected 2,364 patients into the analysis. Both mean SBP and DBP levels significantly decreased in the HI group compared to control group at each follow-up visit with the between group difference of −4.63 mm Hg (95% CI, −6.51 to −2.74) at week 8, −6.69 mm Hg (95% CI, −8.54 to −4.85) at week 16, −7.81 mm Hg (95% CI, −9.57 to −6.04) at week 24 for SBP, and −1.83 mm Hg (95% CI, −3.21 to −0.45) at week 8, −2.57 mm Hg (95% CI, −3.97 to −1.17) at week 16, −2.89 mm Hg (95% CI, −4.24 to −1.54) at week 24 for DBP. …”

Forest plot for subgroups of analysis types. by Shangtian Wang (20933822)

The results of linear mixed model. by Soheila Qanbari (20455173)

“…The tDCS group demonstrated a significant decrease in AMT of MF and TrA/IO muscles (P < 0.05) and an increase in N80 amplitude (P = 0.027), with no significant changes in the control group. …”

Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

“…The tDCS group demonstrated a significant decrease in AMT of MF and TrA/IO muscles (P < 0.05) and an increase in N80 amplitude (P = 0.027), with no significant changes in the control group. …”

Flowchart of literature screening process. by Shangtian Wang (20933822)

“…Subgroup analyses revealed a significant prevention of serious infections (OR = 0.40, 95%CI 0.25-0.64, p = 0.0001). …”

Basic characteristics of included literature. by Shangtian Wang (20933822)

“…Subgroup analyses revealed a significant prevention of serious infections (OR = 0.40, 95%CI 0.25-0.64, p = 0.0001). …”

Raw data. by Shangtian Wang (20933822)

“…Subgroup analyses revealed a significant prevention of serious infections (OR = 0.40, 95%CI 0.25-0.64, p = 0.0001). …”

Forest plot of overall analysis results. by Shangtian Wang (20933822)

“…Subgroup analyses revealed a significant prevention of serious infections (OR = 0.40, 95%CI 0.25-0.64, p = 0.0001). …”

Forest plot for subgroups of infection types. by Shangtian Wang (20933822)

“…Subgroup analyses revealed a significant prevention of serious infections (OR = 0.40, 95%CI 0.25-0.64, p = 0.0001). …”

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Table 1_Metabolic changes after growth hormone treatment in children with growth hormone deficiency and small for gestational age: LG observational study.docx by Sujin Kim (225506)

“…ALT levels significantly decreased in all follow-up years in the GHD group. …”

Baseline characteristics of the study sample^βμ. by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”

The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”

The screening process of MN705. by Wencheng Jin (13136262)